Skip to main content
. 2020 Mar 30;48(9):4946–4959. doi: 10.1093/nar/gkaa189

Figure 5.

Figure 5.

The representative compounds targeting to hcLRS. (A) The compound name, structure and targeting site are listed; the binding of leucine (B) and leucinol (C) in the aminoacylation active site are generated based on the structure of hcLRS-LeuAMS; (D) The BC-LI-0186 binding site (red color) in the proposed hcLRS-tRNALeu model.